2025-10-30
Financial Times
6 related
Life sciences group Thermo Fisher agrees to acquire PE-owned drug trial software maker Clario for $9.4B in an all-cash deal expected to close by mid-2026
Oliver Barnes / Financial Times :
2024-07-17
Reuters
6 related
Israel-based CytoReason, which uses AI to develop disease models, raised $80M from Nvidia, Pfizer, Thermo Fisher, and OurCrowd, and plans a Massachusetts office
Israel's CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.
Loading articles...